Scrutinizing Deleterious Nonsynonymous SNPs and Their Effect on Human POLD1 Gene

Genet Res (Camb). 2022 May 11:2022:1740768. doi: 10.1155/2022/1740768. eCollection 2022.

Abstract

POLD1 (DNA polymerase delta 1, catalytic subunit) is a protein-coding gene that encodes the large catalytic subunit (POLD1/p125) of the DNA polymerase delta (Polδ) complex. The consequence of missense or nonsynonymous SNPs (nsSNPs), which occur in the coding region of a specific gene, is the replacement of single amino acid. It may also change the structure, stability, and/or functions of the protein. Mutation in the POLD1 gene is associated with autosomal dominant predisposition to colonic adenomatous polyps, colon cancer, endometrial cancer (EDMC), breast cancer, and brain tumors. These de novo mutations in the POLD1 gene also result in autosomal dominant MDPL syndrome (mandibular hypoplasia, deafness, progeroid features, and lipodystrophy). In this study, genetic variations of POLD1 which may affect the structure and/or function were analyzed using different types of bioinformatics tools. A total of 17038 nsSNPs for POLD1 were collected from the NCBI database, among which 1317 were missense variants. Out of all missense nsSNPs, 28 were found to be deleterious functionally and structurally. Among these deleterious nsSNPs, 23 showed a conservation scale of >5, 2 were predicted to be associated with binding site formation, and one acted as a posttranslational modification site. All of them were involved in coil, extracellular structures, or helix formation, and some cause the change in size, charge, and hydrophobicity.

MeSH terms

  • DNA Polymerase III* / chemistry
  • DNA Polymerase III* / genetics
  • DNA Polymerase III* / metabolism
  • Humans
  • Lipodystrophy* / complications
  • Lipodystrophy* / genetics
  • Lipodystrophy* / pathology
  • Mutation
  • Polymorphism, Single Nucleotide / genetics
  • Syndrome

Substances

  • POLD1 protein, human
  • DNA Polymerase III